Uncategorized

The Bailout and Physician Dispensing

Talk about a long week!  Those times inevitably come when we reach our limit.  Today’s post will take a slight departure toward the silly in the hope of escaping the world of difficulties surrounding us.  A week of world economic crisis mingled with a nauseating stream of politics has left me quite numb.  Let’s shift gears toward something a bit lighter and that has nothing to do with any bailouts…

A search for funny medical stories and physician humor reveals a number of entertaining sites:

WebMD Physician Humor

You Might Be an ER Physician if..

More Chart Humor

Funny Medical Stories

Ok.  Now I feel much better!  Though my blog is supposed to focus on physician dispensing, medical supplies and other practice opportunities, I think we can afford to depart the path once in a while.

Please submit any humorous stories of your own and I’ll be happy to share.

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading